ASX:ADO

ANTEO DIAGNOSTICS LIMITED

ANTEO DIAGNOSTICS LIMITED has not announced any capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

< $50k

Investors Interested in Next Raise

< 10

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Company Overview

Anteo Diagnostics Limited (ADO) is a global nano-technology company. They work to enable the next wave of technological advancements, irrespective of industry, by tackling the scientific challenges encountered at the quantum (or nanoscale) level. Anteo owns a growing suite of patented technologies in nanometre-thin 'primers', 'binders' and 'coatings'. The Company operates in life sciences sector and its flagship product is Mix&Go.. Anteo also develops, manufactures and distributes products for the life sciences, clinical diagnostics and bio-separations markets and is creating new applications in the energy and medical devices sectors. Life science and diagnostics customers are experiencing important benefits from the Anteo technology around nanoparticles and other miniaturised formats applicable to point-of-care devices. Former Names S.S.H. Medical Limited (SSH), 23/01/2006; Biolayer Corporation Limited (BLS), 24/11/2008

Type

Listed Company

GICS Sub-industry

Life Sciences Tools & Services

Head Office

1 Clunies Ross Ct, Eight Mile Plains QLD 4113, Australia

Website

www.anteotech.com

Life Sciences Tools & Services

Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.